Print
Health Care

New Lab In Wisconsin Expands Wilmington Based PPD's Testing Capabilities

By Jenny Callison, posted Mar 29, 2018
PPD this week announced a new analytical laboratory at its existing facility in Middleton, Wisconsin. The lab will expand PPD’s testing capacity, according to an announcement Wednesday by the Wilmington-based company.

The 32,000-square-foot Good Manufacturing Practices (GMP) lab “supplements the company’s existing biologics capacity and was constructed specifically for the stability and quality control testing of large molecule drug products,” the news release stated.

Planned for a workforce of more than 100, the new lab contains specialized areas designed for particular types of assays and scientific instrumentation specific to biologics, according to the release.

Biological products, or biologics, include a wide range of products such as vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues and recombinant therapeutic proteins.

According to the Federal Drug Administration, biologics – as distinguished from chemical synthetics – are products isolated from a variety of natural sources. 

“The expansion of our biologics testing, which nearly doubles our analytical testing capacity, enables us to meet the ever-growing needs of our clients for GMP testing of large molecule products,” Jon Denissen, senior vice president of the PPD Laboratories bioanalytical and GMP labs, said in the release. “From early clinical development through commercial release testing, clients rely on our industry-leading capabilities in large molecule product testing. With deep expertise that spans the full spectrum of protein-based and gene-based biologics, we support many of the most cutting-edge immuno-oncology, gene therapy and cell therapy agents being developed or marketed today.”

PPD is also renovating its existing cell lab at the Middleton campus to double the lab’s capacity for GMP cell-based assays, the release stated, adding, “The expanded 5,900-square-foot laboratory will support a total of 70 cellular and molecular biology scientists upon its completion in mid-2018.”
Ico insights

INSIGHTS

SPONSORS' CONTENT
20180514 104209 51418120638

What is SOLA?

Steve Adams - School of Learning Arts
Yasminheadshotwithlogo

Word Power

Yasmin Tomkinson - Cape Fear Literacy Council
Karagansmanncshlaw300x300

Essential Estate Planning Documents for Young Adults

Kara Gansmann - Cranfill Sumner & Hartzog LLP

Trending News

NHRMC Launches Innovation Center At TekMountain

Christina Haley O'Neal - Aug 13, 2018

RiverLights Submits Plans For Additional Homes

Christina Haley O'Neal - Aug 14, 2018

Three People Join Live Oak Bank’s SBA Lending Team

Christina Haley O'Neal - Aug 14, 2018

Wilmington Eye Merges With Coastal Carolina Eye Clinic

Johanna Cano - Aug 14, 2018

Friends Of Fort Fisher Announces New Executive Director

Christina Haley O'Neal - Aug 14, 2018

In The Current Issue

NHRMC Earns National Cancer Accreditation

The Commission on Cancer recently granted three-year accreditation to the cancer program at New Hanover Regional Medical Center....


Program Addresses Funding Gap

A program designed to help female entrepreneurs bridge the funding gap drew a number of local startups this year....


NPF Corp. Acquires Aquesta Insurance

Aquesta Insurance Services, formerly part of Cornelius, North Carolina-based Aquesta Bank, has a new owner....

Book On Business

The 2018 WilmingtonBiz: Book on Business is an annual publication showcasing the Wilmington region as a center of business.

Order Your Copy Today!


Galleries

Videos

2018 Power Breakfast - Dishing on the Restaurant Biz
2018 WilmingtonBiz Expo - Keynote Lunch with Eric Dinenberg, Rouse Properties
2017 Health Care Heroes